Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
NRG Oncology
InxMed (Shanghai) Co., Ltd.
Merck Sharp & Dohme LLC
National Cancer Institute (NCI)
NRG Oncology
Radiation Therapy Oncology Group
Innovent Biologics (Suzhou) Co. Ltd.
Sun Yat-sen University
Tianjin Medical University Cancer Institute and Hospital
Fondazione Humanitas per la Ricerca